PAMIDRONATE MEDAC 3MG/ML INF CNC SOL 1X20ML

What is the maximum co-payment for PAMIDRONATE MEDAC?

If the insurance company contributes, the maximum co-payment is 877,34 Kč. The maximum pharmacy price is 2 064,61 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

Yes, but only during an outpatient procedure. When dispensed on prescription, the patient always pays the full price.

Does PAMIDRONATE MEDAC have a counted co-payment set?

No, this medicine has no counted co-payment.

How much does the insurance company pay for one dispensed reimbursed pack?

1 187,27 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

Kyselina pamidronová pro parenterální podání je hrazena:
1. u pacientů s destrukcí kostí a hyperkalcémií provázející zhoubné nádory s kostními metastázami nebo bez nich,
2. u mnohočetného myelomu
3. u manifestní Pagetovy choroby.

Rychlý přehled

Dosage form Solution concentrate infusion
Výdej Ne, lék nelze získat bez receptu.
Úhrada / doplatek / cena Ano, ale pouze při ambulantním výkonu. Při výdeji na recept platí pacient vždy plnou cenu. Maximální doplatek: 877,34 Kč. Maximální cena: 2 064,61 Kč.
Kdo může předepsat clinical oncology, pediatric oncology and hematology, radiation oncology and oncogynecologyhematology and transfusion medicine, pediatric oncology and hematologyinternal medicineortopedi…
Složení More information about the composition can be found in the SPC, section 6.1.
Dostupnost / výpadek The latest report from the manufacturer is from 5. 4. 2011. Výroba je oficiálně zahájena od 1. 1. 2008.
Kód SÚKL 0050699

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe PAMIDRONATE MEDAC?

  • clinical oncology, pediatric oncology and hematology, radiation oncology and oncogynecology
  • hematology and transfusion medicine, pediatric oncology and hematology
  • internal medicine
  • orthopedics and traumatology of the locomotor system, traumatology
  • rheumatology, pediatric rheumatology
  • endocrinology
  • clinical osteology

What is the composition of PAMIDRONATE MEDAC?

. More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

  • Documents could not be found v lokální importní databázi.

Which medicines are similar to PAMIDRONATE MEDAC?

The medicine belongs to ATC group M05BA03. Název skupiny není v lokální importní databázi dostupný.

Who manufactures PAMIDRONATE MEDAC?

Informace o výrobci není dostupná.

Is the medicine in shortage?

The latest report from the manufacturer is from 5. 4. 2011. Production has been officially started as of 1. 1. 2008.

What is the unique code for PAMIDRONATE MEDAC?

The medicine has code 0050699. Code details can be found here.

How many packs of PAMIDRONATE MEDAC were previously dispensed on prescriptions in Czechia?

Show prescription medicine consumption

How many packs of PAMIDRONATE MEDAC were previously dispensed on request forms in Czechia?

Show request-form medicine consumption

Z čeho se skládá maximální cena léku?

The page was last updated on 22. 06. 2026

SIMILAR MEDICINES: